Labeling error spurs Canada’s Aphria to recall medical cannabis

A licensed producer of medical marijuana in Ontario has recalled a small quantity of dried marijuana due to a labeling error.

Leamington, Ontario-based Aphria issued the voluntary recall for 2 a lot of dried marijuana bought in 10-gram bottles produced between Jan. 19 and Jan. 22.

The labels failed to embrace a % signal subsequent to the numerical values for cannabinoid content material, in accordance to recall notification from Health Canada.

The recall was initiated Jan. 25.

It’s a Type III recall, which means affected merchandise are unlikely to trigger opposed well being penalties.

Health Canada stated it hasn’t acquired any reviews of opposed reactions.

An Aphria spokesperson didn’t instantly return a name from Marijuana Business Daily.

It’s the second time in lower than a yr Aphria has recalled medical cannabis due to a labeling mishap.

On March eight, 2017, the corporate voluntary recalled dried marijuana due to mislabeling.

Meanwhile, three of Canada’s 10 MMJ recollects up to now yr have stemmed from labeling errors. Aurora Cannabis’ recall in November is the newest incident.

Aphria and Aurora are traded on the Toronto Stock Exchange beneath the symbols APH and ACB, respectively.

To join our weekly Canada marijuana enterprise publication, click on right here.

Categories: Briefs, Canada Marijuana News, Marijuana Stocks & Public Companies, Uncategorized


Be the first to comment

Leave a Reply

Your email address will not be published.